NCT00768820

The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome

The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 400 (estimated)
• Sponsor: The Chaim Sheba Medical Center · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to investigate the Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors

Conditions

• Velocardiofacial Syndrome
• Williams Syndrome
• Fragile X Syndrome

Interventions

Type	Name	Description
DRUG	methylphenidate, fluoxetin, risperidone	first cognitive evaluation without methylphenidate,second cognitive evaluation with methylphenidate

Timeline

• Start date: 2001-05-01
• Primary completion: 2027-08-01
• Completion: 2027-08-01
• First posted: 2008-10-08
• Last updated: 2026-03-18

Locations

1 site across 1 country: Israel